# Sunshine Insurance Group

> Sunshine Insurance Group is a VC fund backing Health Care and Biotechnology. See 27 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 27
- Last investment: Mar 2026
- Lead investor: 30%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/sunshine-insurance-group
- X (Twitter): https://twitter.com/sinosig
- Website: http://www.sinosig.com/

Sunshine Insurance Group is a VC fund in Beijing focused on Health Care and Biotechnology. Sunshine Insurance Group Company Limited provides insurance products and services.

## Contacts

5 contacts available for Sunshine Insurance Group. Shizune tracks 2 team members at Sunshine Insurance Group. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/sunshine-insurance-group-co-ltd?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series B | $11M–$184M |
| Series C | $4.3M–$460M |
| Series D | $7.1M–$200M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 19% |
| Biotechnology | 5 | 19% |
| Medical | 4 | 15% |
| Internet | 3 | 11% |
| Artificial Intelligence | 3 | 11% |

51 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 12 | 44% |
| Series B | 7 | 26% |
| Series D | 3 | 11% |
| Series E | 2 | 7% |
| Angel | 1 | 4% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 24 | 89% |
| United States | 1 | 4% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Phil Tian | Chief Data Scientist, Big Data Centre | 0 | https://shizune.co/investors/profile/fengzhan-tian |
| Zhang Weigong | Founder | 0 | https://shizune.co/investors/profile/zhang-weigong |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hugemed | Hugemed manufactures of medical devices and provides solutions in the field of endoscopy. |  | Series C | Mar 30, 2026 |  |
| Bang Er Orthopedic | Zhejiang Boner Medical Investment Management Co., Ltd. is a well-known professional hospital investment operator in the Yangtze River Delta, featuring major orthopaedics and rehabilitation. | $109.8M | Series E | Nov 09, 2023 |  |
| Data Grand | Data Grand is a semantic analysis solution developer. | $91.8M | Series C | Mar 09, 2022 |  |
| Grit Science | Grit Science is a gene therapeutics firm, that engages in the R&D of liver genes. | $15M | Series A | Mar 02, 2022 |  |
| ChangXin Memory Technologies | ChangXin Memory Technologies specializes in manufacturing dynamic random-access memory (DRAM) semiconductor products. | $1.2B | Series C | Feb 17, 2022 |  |
| Zaihui | Zaihui is a SaaS-based data-driven marketing automation solution for local businesses that offers them with member management, precipitation members, incentive members, and mining member values. Product system offers intelligent precision marketing, integral marketing, stored-value marketing, anniversary marketing, attendant performance, thememarketing activities, and brand packaging marketing.Zaihui is headquartered in China and the company was founded in 2015. | $200M | Series D | Jan 11, 2022 |  |
| ImmuneOnco Biopharma | ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. | $100M | Series C | Jan 01, 2022 |  |
| XuanZhu Pharma | XuanZhu Pharma is an innovative biopharmaceutical company rooted in China, with a global perspective, focusing on tumors, metabolic diseases, infections, and other fields. It has a layout of the entire industry chain from drug discovery, preclinical research, clinical development, and production and sales. | $96.1M | Series B | Dec 31, 2021 |  |
| ImmuneOnco Biopharma | ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. | $100M | Venture - Series Unknown | Dec 31, 2021 |  |
| Neurophth Therapeutics | Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally. | $60M | Series C | Nov 23, 2021 |  |

10 of 27 investments shown.

## Co-investors
- [China Merchants Securities](https://shizune.co/investors/profile/china-merchants-securities) — VC Fund, 3 deals together
- [Ant Group](https://shizune.co/investors/profile/ant-group) — VC Fund, 2 deals together
- [CASH Capital](https://shizune.co/investors/profile/cash-capital) — VC Fund, 2 deals together
- [CCB Trust](https://shizune.co/investors/profile/ccb-trust-co) — VC Fund, 2 deals together
- [CDF-Capital](https://shizune.co/investors/profile/cdf-capital) — VC Fund, 2 deals together
- [DT Capital Partners](https://shizune.co/investors/profile/dt-capital-partners) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [RRE Ventures](https://shizune.co/investors/profile/rre-ventures) — VC Fund
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund
- [1745 Ventures](https://shizune.co/investors/profile/bertelsmann-digital-media-investments) — VC Fund

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Publishing Investors in China](https://shizune.co/investors/publishing-investors-china)
- [Publishing VC Funds in China](https://shizune.co/investors/publishing-vc-funds-china)

## FAQ

### What does Sunshine Insurance Group invest in?

Sunshine Insurance Group invests primarily in Health Care, Biotechnology and Medical startups, most often at Series C and Series B stage. Most of the 27 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Sunshine Insurance Group's check size?

Sunshine Insurance Group typically joins rounds of $11M–$184M at Series B, $4.3M–$460M at Series C and $7.1M–$200M at Series D. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sunshine Insurance Group participates in.

### How do I contact Sunshine Insurance Group?

Public channels for Sunshine Insurance Group include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Sunshine Insurance Group?

The team at Sunshine Insurance Group includes Phil Tian (Chief Data Scientist, Big Data Centre) and Zhang Weigong (Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co